#United States #Joe Meisch #Temple Massager #MOQ Collective #Cazadero

Introduction

This Veterans Day, we celebrate the remarkable journey of Army veteran Joe Meisch and his innovative project, the Temple Massager. Partnering with MOQ Collective and People Science, this small but mission-driven brand is setting a precedent for how clinical evidence can be generated, even by businesses that are often sidelined. With over 15 years of experience and significant contributions to the health and wellness of service members and first responders, Meisch is pushing forward to ensure that his product has credible clinical backing.

Background of the Temple Massager

The Temple Massager is a hand-held, drug-free self-massage tool designed to alleviate stress and tension. For over a decade, Meisch has provided more than 6,000 units to service members and first responders, gathering enthusiastic feedback in the form of signed letters from commanders and healthcare professionals alike. However, he recognized the need for formal clinical data that health systems and potential employers seek before endorsing a product. He stated, "I know what it feels like when the stress and tension build up... Now we have research behind what I've been hearing from people for years."

The Research Process

In collaboration with MOQ Collective, Meisch was able to launch an observational study through the People Science® platform called Chloe®. This IRB-approved study (ClinicalTrials.gov NCT07639658) engaged women aged 35 to 65, focusing on those with recurring headaches and facial tension. Within just 12 hours, enrollment reached capacity with 68 participants.

The participants used the Temple Massager daily while tracking their experiences through the Chloe app, all conducted remotely without the need for physical site visits. The study monitored multiple health dimensions, targeting anxiety, quality of life, and pain management.

Key Findings from the Study

The results have been promising:

• - A majority of participants (30 out of 35 in the main analysis) demonstrated a significant decrease in anxiety levels, with scores averaging a drop from 9.91 to 5.11 on a validated anxiety measure, indicating meaningful clinical improvement.
• - Improvements were noted in 7 out of 8 quality-of-life domains, including fatigue, sleep quality, and pain interference.
• - Participants reported fewer headache days and a reduced need for over-the-counter pain medication, seeing a decline from an average of 1.66 to 0.71 usage days per week.
• - Throughout the entire study, there were no adverse events reported across all 286 check-ins, showcasing the product's safety.

Colleen Quinn, principal investigator at MOQ Collective, emphasized that small, mission-driven brands shouldn’t be excluded from contributing clinical data. She said, "Women's health has waited too long for evidence, and small brands are often priced out of producing it. The study demonstrates that a well-designed, remote study can yield significant results for these entities."

Future Directions

Following these encouraging results, Meisch plans to engage with employers, health systems, and governmental entities to share the findings and advocate for broader accessibility of the Temple Massager. His vision includes ensuring every U.S. 911 dispatch center has access to this stress relief tool.

The groundbreaking work achieved through this partnership illustrates how veterans can lead in innovative health solutions while also proving that mission-driven brands are capable of producing rigorous clinical evidence. As the landscape of health and wellness continues to evolve, stories like that of the Temple Massager remind us of the critical role small businesses play in providing relief and support to those who need it most.

About the Partners

Meisch Temple Massager, Inc. is a certified Service-Disabled Veteran-Owned Small Business located in Cazadero, California. Founded by Joe Meisch, the company specializes in manufacturing the Temple Massager, a unique self-care tool made in the USA.

MOQ Collective is dedicated to bridging the gap between clinical evidence and the market, assisting wellness brands in navigating clinical trial design, regulatory requirements, and storytelling.

People Science operates as a decentralized contract research organization, facilitating rigorous, remote studies via their Chloe® platform, which currently boasts a community of over 65,000 participants.

Conclusion

The combination of Joe Meisch's experience, the dedication of MOQ Collective, and the innovation from People Science illustrates how the community can support mission-driven brands in achieving their goals. As they work towards conquering the health challenges faced by many, they set a strong example of what's possible when passion meets purpose.